Relizen Nominated for 2014 Women’s Health Award for SupplySide Editor’s Choice Awards
New York, NY (PRWEB) October 06, 2014 -- Relizen®, a patented, non-hormonal nutritional supplement for the relief of hot flashes associated with menopause, has been nominated as a finalist for the 2014 SupplySide CPG Editor’s Choice Awards.
Relizen was named among the top five nominees in the Women’s Health category by the SupplySide editorial team for innovation and market impact in the field of women’s health.
Recently launched in the United States, Relizen is a patented, non-hormonal nutritional supplement for the relief of hot flashes associated with menopause. Relizen has been used by over one million women across Europe, and has been among France’s best-selling menopause products for several years. Relizen’s success overseas is heavily attributed to the fact that it is non-hormonal and relieves hot flashes with no estrogenic effect. Across all studies, Relizen has not been linked to side effects or adverse reactions different from placebo (a sugar pill).
“We are honored to be recognized by one of the premier organizations in the health and wellness industry with this nomination for an Editor’s Choice Award,” said Michael Satow, CEO of JDS Therapeutics, the makers of Relizen. “We are excited to share this effective and safe therapy for women with hot flashes in the U.S. JDS Therapeutics is proud that we offer a product that can help to truly meet an unmet need in women’s health.”
Supported by an Expert Physician Advisory Board composed of leaders in the field of women’s health, Relizen is also backed by a number of studies published in leading medical journals. Studies on the Relizen product have been published in several medical journals, including Climacteric, Menopause, Genesis, and Cancers Au Feminin.*
Relizen’s active ingredient is made from a purified Swedish flower pollen extract, which contains over 180 nutrients. The Swedish flowers used to make Relizen are grown without pesticides and harvested in the fields of southern Sweden according to Good Agricultural and Collection Practices. A proprietary state-of-the-art biotechnology process is used to ensure every tablet of Relizen is easily absorbed by the body and has pollen allergens removed.
One winner in each category will be announced at SupplySide West 2014 during the SupplySide CPG Editor’s Choice Awards Reception, set for Wednesday, October 8, 2014, at the Mandalay Bay Resort in Las Vegas, Nevada.
To find out more about Relizen, visit http://www.Relizen.com.
About SupplySide West
For more than 15 years, SupplySide has helped dietary supplement, food, beverage, personal care and cosmetic professionals find information to explore, discover, innovate and market their next best-selling product.
"In the past few years we’ve had tremendous success highlighting the products that are coming to market, driven by the innovative ingredients highlighted at SupplySide," said Heather Granato, vice president, content, in Informa’s Health & Nutrition Network. "Our editorial team was impressed this year at the range of products and out-of-the-box thinking that these companies are putting into product development to reach their target markets."
For more information, visit supplysideshow.com.
About JDS Therapeutics
JDS Therapeutics markets proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. JDS is focused on providing patients with scientifically backed, natural approaches to meeting their healthcare needs, and owns more than 100 issued or pending patents worldwide involving clinically active natural compounds.
Relizen® is a registered trademark of JDS Therapeutics, LLC.
*Sources cited:
Winther K, Rein E, Hedman C. [Relizen] — herbal remedy made from pollen extracts, reduces hot flashes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climacteric. 2005;8:162-170.
Hellström A., Muntzing J. The pollen extract [Relizen] –a nonestrogenic alternative to hormone therapy in women with menopausal symptoms. Menopause. 2012;19(7):825-829.
Elia D, Mares P. Assessment of the tolerance and effectiveness of a food supplement [Relizen] for menopausal women. Genesis. 2008;135:12-15.
Espié, Marc. Bouffées de chaleur et cancer du sein: Quelle prise en charge efficace et sans risqué? Cancers Au Feminin. 2014,3:1-16.
Elizabeth Maxim, Marketing Maven, +1 (310) 994-7381, [email protected]
Share this article